| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 46,685 | 35,036 | 25,509 | | Cost of Revenue | 16,503 | 15,124 | 13,506 | | | Gross Profit | 30,181 | 19,912 | 12,002 | | | Operating Expenses | | Research Development | 6,111 | 6,353 | 5,323 | | Selling General and Administrative | 33,211 | 23,210 | 17,091 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (9,141) | (9,652) | (10,411) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 520 | 1,365 | (4,010) | | Earnings Before Interest And Taxes | (8,621) | (8,286) | (14,421) | | Interest Expense | 85 | 1,647 | 998 | | Income Before Tax | (8,706) | (9,933) | (15,419) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (8,706) | (9,933) | (15,419) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (8,706) | (9,933) | (15,419) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($8,706) | ($9,933) | ($15,419) |
|
0.36% Nasdaq 
Income Statement
